Navigation Links
Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced

A new class of hybrid virus that can identify, highlight and deliver genes to mice tumor cells have been developed by researchers // at the University of Texas M. D. Anderson Cancer Center. This new development, reported in the journal Cell, marks a milestone in cancer research as it could lead to novel treatment strategies for combating cancer.

As the technique increases the visibility of the cancer cells and makes it more accessible to treatment, it might allow precise monitoring of how certain anti-cancer agents work. 'In tumor-bearing mice, we show that this hybrid virus can target tumors systemically to deliver an imaging or therapeutic gene. The signal is specific only to tumors, so one can monitor drug effectiveness at the molecular level,' said Renata Pasqualini, the co-leader of the study.

The hybrid virus was created by a culmination of the biological characteristics and genetic components of an animal virus. The new hybrid virus named as AAV phage or AAVP can be used as a vehicle for delivery of specific genes targeted at tumors in mice produced through appropriate techniques.

This technique of genetically marking a tumor could eventually lead to a strategy for detection on a clinic-ready body scanner. The unique ability of the hybrid virus to deliver genes or other agents into the cells in addition to targeting specific tissues represents a distinct advantage. What surprised the researchers is that the hybrid viruses retained the properties of the parental viruses, from which they were derived.

'This is only a proof-of-concept, and although we have yet to translate these hybrid viruses for use in humans, we hope that this new system will have future clinical applications. In addition to the obvious biological interest, when the vector is refined for patient use, it could perhaps help us diagnose, monitor and treat human tumors more accurately,' said Wadih Arap, co-leader of the study.

As the n ext step, the researchers intend to design studies to evaluate the safety and efficacy of the hybrid vectors in animal models designed to mimic human models of cancer. If successful results are obtained, the research would concentrate on ways and means to adapt and optimize the AAVP-based tumor targeting for use in cancer patients.

The researchers referred to the new technique as a 'theragnostic' approach. In other words, it is a combination of the diagnostic and therapeutic modalities. With research such as this offering endless hope in the diagnosis and treatment of cancer, a cure for the disease is not very far.


'"/>




Related medicine news :

1. Molecular markers for early diagnosis of breast and ovarian cancer
2. Scientists Developed Map For Brain Molecular Communities
3. Molecular Mechanism Of HIV Infecting The Healthy Cells Discovered.
4. Molecular Flaw Detected in Aggressive Breast Cancers
5. Molecular Computer Developed To perform Calculations From Within Human Body
6. Molecular Basis Of ALS Found
7. New Molecular Treatment Identified To Treat Blood Cell Cancers
8. Researchers Find Molecular "Brake" to Cell Death
9. Solitons Could Power Molecular Electronics, Artificial Muscles
10. Discovery of Agile Molecular Motors Could Aid in Treating Motor Neuron Diseases
11. Joint Center for Molecular Modeling Instituted by Burnham Institute for Medical Research & UC San Diego
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs from biotech, pharmaceutical, ... and 31st at The Four Seasons Hotel Boston. , The Boston CEO ... offering exclusive access to key decision makers who influence deal making and investment. ...
(Date:5/26/2017)... ... May 26, 2017 , ... Somnoware, ... NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware SDI ... diagnostic device operations. With this platform, initializing devices and importing studies are just ...
(Date:5/26/2017)... ... May 26, 2017 , ... via seating ... mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper Mesh ... to partner with Cupron® to provide customers with a game changing chair that ...
(Date:5/26/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... being discussed by President Donald Trump and the rest of the world. Donald Trump ... peace talks in the continuous battle between Israel and Palestine. The world’s eyes are ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral ... new, informational blog post on insurance options. If a Bay Area patient has to ... save time and money. Visiting an in-network provider for a second opinion can ensure ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... -- Two Bayer U.S. Pharmaceutical leaders received top awards from ... th Woman of the Year event ... mission of furthering the advancement and impact of women ... Powell-Steffen , senior director of brand activation and inside ... Howe , a regional business manager for New England ...
(Date:5/11/2017)... 2017  Thornhill Research Inc. ( Toronto, ... $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by the ... Corporation (CCC) ( Ottawa, Ontario, Canada ... general anesthesia to patients requiring emergency medical procedures ... Marine Corps have been a longtime partner with ...
(Date:5/10/2017)... Md. , May 10, 2017 CSSi, ... solutions for the clinical research industry, is proud to ... www.CSSiEnroll.com . The new website features both enriched content ... user experience and enhances the company,s already well-established position ... industry. "After many months of hard ...
Breaking Medicine Technology: